- Metronidazole is commonly used antibiotic in periodontal therapy that is effective against anaerobic bacteria. It can attain effective concentrations in gingival tissues, saliva, and crevicular fluid.
- Systemic antibiotic therapy with metronidazole should be reserved for acute periodontal infections, as an adjunct to periodontal treatment, or for patients who continue experiencing periodontal breakdown despite treatment.
- When using metronidazole, it is recommended to not use it as a monotherapy but combine it with other antibiotics like amoxicillin or ciprofloxacin. Common dosing regimens include 250mg of metronidazole three times daily combined
The Gram-negative A. actinomycetemcomitans is assumed to be the primary etiologic agent of LAgP and has also been implicated in chronic periodontitis and severe non-oral infections.
Porphyromonas gingivalis belongs to the phylum Bacteroidetes and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.
It is found in the oral cavity, where it is implicated in certain forms of periodontal disease, as well as in the upper gastrointestinal tract, the respiratory tract, and the colon. It has also been isolated from women with bacterial vaginosis. Collagen degradation observed in chronic periodontal disease results in part from the collagenase enzymes of this species. It has been shown in an in vitro study that P. gingivalis can invade human gingival fibroblasts and can survive in them in the presence of considerable concentrations of antibiotics.P. gingivalis also invades gingival epithelial cells in high numbers, in which cases both bacteria and epithelial cells survive for extended periods of time. High levels of specific antibodies can be detected in patients harboring P. gingivalis. Dr Harshavardhan Patwal , explains the various enzymes enzyme peptidyl-arginine deiminase, which is involved in citrullination.[4] Patients with rheumatoid arthritis have an increased incidence of periodontal disease, and antibodies against the bacterium are significantly more common in these patients.
P. gingivalis is divided into K-serotypes based upon capsular antigenicity of the various types.
this presentation is on the relationship and effect of nutrition on general and oral health
management of few cases and pictures of the same are also included
Inflammation and Immunity in periodontitis pptPerio Files
Local destruction of periodontium occurs mostly by activation of immune and inflammatory response, initiated by plaque. First innate immune response is activated followed by specific immune response.
Useful for BDS and MDS students
T-cells is explained with a emphasis with humoral and adaptive immunity . And the diffrent subsets of t cells are well explained by Dr Harshavardhan Patwal here .
The Gram-negative A. actinomycetemcomitans is assumed to be the primary etiologic agent of LAgP and has also been implicated in chronic periodontitis and severe non-oral infections.
Porphyromonas gingivalis belongs to the phylum Bacteroidetes and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.
It is found in the oral cavity, where it is implicated in certain forms of periodontal disease, as well as in the upper gastrointestinal tract, the respiratory tract, and the colon. It has also been isolated from women with bacterial vaginosis. Collagen degradation observed in chronic periodontal disease results in part from the collagenase enzymes of this species. It has been shown in an in vitro study that P. gingivalis can invade human gingival fibroblasts and can survive in them in the presence of considerable concentrations of antibiotics.P. gingivalis also invades gingival epithelial cells in high numbers, in which cases both bacteria and epithelial cells survive for extended periods of time. High levels of specific antibodies can be detected in patients harboring P. gingivalis. Dr Harshavardhan Patwal , explains the various enzymes enzyme peptidyl-arginine deiminase, which is involved in citrullination.[4] Patients with rheumatoid arthritis have an increased incidence of periodontal disease, and antibodies against the bacterium are significantly more common in these patients.
P. gingivalis is divided into K-serotypes based upon capsular antigenicity of the various types.
this presentation is on the relationship and effect of nutrition on general and oral health
management of few cases and pictures of the same are also included
Inflammation and Immunity in periodontitis pptPerio Files
Local destruction of periodontium occurs mostly by activation of immune and inflammatory response, initiated by plaque. First innate immune response is activated followed by specific immune response.
Useful for BDS and MDS students
T-cells is explained with a emphasis with humoral and adaptive immunity . And the diffrent subsets of t cells are well explained by Dr Harshavardhan Patwal here .
The periodontal examination should be systematic, starting in the molar region in either maxilla or mandible and proceeding around the arch. It is important to detect the earliest signs of gingival and periodontal disease.
- Wat betekenen social media voor uw organisatie?
- Social media en organisaties: waar gaat het mis?
- Social media en organisaties: hoe moet het dan wel?
(presentatie gegeven door Davy Vandevinne tijdens het congres van de Vlaamse Vereniging voor Zakelijke Communicatie op 24 november 2011)
Keys to Understanding and Leveraging the power of Sina Weibo in ChinaLabbrand
Sina Weibo stands out not only through its functionality but also through the way it is used by its millions of members. Its influence and penetration make it a powerful medium for brands that can leverage its power to establish deeper, more intense relationships with local consumers. However, tapping the full power of Sina Weibo as a marketing tool calls for a strategic approach that integrates brand objectives, customer expectations and the specificities of the platform.
Шавкова В., Волкова А., Хандута А. Проект для "КонсультантПлюс Илан"prasu1995
Проект для компании «КонсультантПлюс Илан» (Красноярск)
Авторы: Алина Хандута (ИнАрхДиз АлтГТУ), Алиса Волкова, Вероника Шавкова (Связи с общественностью АлтГУ)
Выполнен в рамках интенсивного практического курса «Мастерская рекламы-3», Барнаул, 2012
The rationale for using antibiotics and chemotherapeutics in the periodontal disease treatment is its polymicrobial nature of disease. Antibiotic use should be done cautiously in treating various periodontal infection as improper use of it can lead to its resistance by bacterial strains. Antibiotic in periodontics is a very helpful adjunct in controlling the bacteria in the oral cavity
“Desquamative Gingivitis Treated By An Antioxidant Therapy- A Case Report”inventionjournals
Desquamative gingivitis is described as an erythematous, desquamated or eroded gingival lesion. Various etiologic factors are present for the appearance of such lesions. Despite of considering etiology, treatment is oftenly provided by systemic or topical corticosteroids. Apart from steroid application, another optionable treatment is antioxidant therapy which provides rapid healing of the tissue. As antioxidants posses various advantageous properties, it can be considered as a first treatment option for desquamative gingivitis. The presented case report of desquamative gingivitis is successfully treated using systemic antioxidants in the form of commercially available „oxitard capsule‟.
“Desquamative Gingivitis Treated By An Antioxidant Therapy- A Case Report”inventionjournals
Desquamative gingivitis is described as an erythematous, desquamated or eroded gingival lesion. Various etiologic factors are present for the appearance of such lesions. Despite of considering etiology, treatment is oftenly provided by systemic or topical corticosteroids. Apart from steroid application, another optionable treatment is antioxidant therapy which provides rapid healing of the tissue. As antioxidants posses various advantageous properties, it can be considered as a first treatment option for desquamative gingivitis. The presented case report of desquamative gingivitis is successfully treated using systemic antioxidants in the form of commercially available „oxitard capsule‟.
“Desquamative Gingivitis Treated By An Antioxidant Therapy- A Case Report”inventionjournals
Desquamative gingivitis is described as an erythematous, desquamated or eroded gingival lesion. Various etiologic factors are present for the appearance of such lesions. Despite of considering etiology, treatment is oftenly provided by systemic or topical corticosteroids. Apart from steroid application, another optionable treatment is antioxidant therapy which provides rapid healing of the tissue. As antioxidants posses various advantageous properties, it can be considered as a first treatment option for desquamative gingivitis. The presented case report of desquamative gingivitis is successfully treated using systemic antioxidants in the form of commercially available „oxitard capsule‟
2. Systemic Metronidazole i n
Periodontal Therapy
Usama M. madany
Professor, Department of Oral Medicine
Periodontology, Diagnosis and Oral Radiology,
Faculty of Dental Medicine , Al-Azhar University
3. - Commonly used antibiotics in periodontal therapy :
Tetrayclines (doxycycline) Metronidazole
Clindamycin Penicillins (amoxicillin)
Erythromycins (azithromycin, clarithromycin)
Ciprofloxacin
The microbial etiology of inflammatory periodontal
diseases provides the rationale for the local and
systemic use of different antibiotics in periodontal
therapy.
4. -Systemic antibiotic therapy in periodontics should be
reserved to the following:
A. Prophylaxis for patients with medical problems requiring
antibiotic coverage.
B. Patients with systemic manifestations associated with
acute periodontal infections (ANUG and acute periodontal
abscess) .
C. As an adjunct to surgical and non surgical periodontal
therapy.
D. Patients who undergo continued periodontal breakdown in
spite of thorough debridement and excellent home care .
5. Metronidazole
Pharmacology and spectrum:
-It is a nitroimidazole compound mainly active against
protozoal infections.
-It is very effective in low reduction potential areas, and
bactericidal to anaerobes through inhibition of DNA
synthesis.
-It can readily attain effective antibacterial concentration in
gingival tissue, saliva and crevicular fluid.
-It is effective against the microorganism strongly
associated with and implicated in pathogenesis of
periodontal disease.
6. % Absorption after Peak serum level Serum half-life
Antibiotic oral adminestration (µg/ml) (hours)
Metronidazole 90 20-25 6-14
Tetracyclines 93 2- 4 18
(Doxycyline)
Clindamycin 90 5 2.4
Penicillins 75 5- 8 1.2
(Amoxicillin)
Ciprofloxacine 70 1.5 4
Erythromycines 37-50 0.4-3 5-12
Selected pharmacological features of common antibiotics in use
for periodontics
9. Clinical use of systemic metronidazole:
If to be used, metronidazole should not be administered as monotherapy.
Alone
1- Treatment of ANUG 2- Treatment of periodontitis
250-500 mg/ tid/ 3-5 days 750-1000 mg /day for 7-14 days*
- growth of anaerobic bacteria.
- histopathological and Clinical
signs of periodontitis.
- the need for surgery.
-Recommended doses :
250 mg/ tid/ 7 days (Greenstien, 1993).
500 mg/ tid/ 8 days (Slots and Ting,
2002)
Loesche 1992; Nieminen et al.1996; Soder 1999.
10. Combined with other antibiotics
-Complexity of periodontal pathogens in dental biofilm
(dental plaque).
-Considerable variation of sensitivity of these bacteria to
different antibiotics.
Treatment of periodontitis:
1- Metronidazole + amoxiciilin 250 mg/ tid/ 8 days of each
drug.
2- Metronidazole 250 mg + amoxycillin-clavulanate
potassium (augmentin) 375 mg / tid/ 8 days.
3- Metronidazole + ciprofloxacin 500 mg/ bid/ 8 days of
each drug.
-These regimens resulted in improved clinical status and suppression
and/or elimination of Aa and Pg in aggressive and recurrent forms of
periodontitis ( Slots and Ting 2002, AAP position paper 2004).
11. Adsverse reactios and side effects:
-Nausia/vomiting
-Unpleasant (metallic) taste.
-Pregnancy: Possible risk of teratogenicity.
Drug Interactions*:
1-Metronidazole metabolism of warfarin prolonged
prothrombin time bleeding tendency (definite action).
2-Metronidazole + Ethanol disulfiram-like reaction:
nausia, vomiting, severe cramps, flushing, sweating,
hypotension, palpitation and headache (probable action).
*Yagiela, 1999, Horn et al.2004
12. 3-Metronidazole metabolism of oral hypoglycemic drugs
Hypoglycemia (probable) .
5-Metronidazole may inhibit the action of estrogen
components of oral contraceptives unexpected
pregnancies ( Hersh 1999).
6-Barbiturates effectiveness of metronidazole (probable).
Precautions on prescription
1-Metronidazole should be avoided in patients undergoing
warfarin therapy.
2-Alcohol containing products should be avoided during
metronidazole therapy and for at least one day after therapy
is discontinued.
13. 3-Metronidazole is better to be avoided for diabetics on
oral hypoglycemic drug.
4-It should be avoided during pregnancy especially in the
first trimester, and also for females on oral contraceptives.
5-In patients with impairment of liver functions,
metronidazole is better to be avoided or its dose to be
decreased.
6-Dose for children should by properly adjusted according
to body weight (7.5 mg/kg 8 hourly).